Dorothy A. Rowan v. HHS - Influenza, Guillain-Barré syndrome (2020)

Filed 2017-06-08Decided 2020-05-29Vaccine Influenza
denied

Case summary [AI summaries can sometimes make mistakes]

On June 8, 2017, Dorothy A. Rowan, individually and as personal representative of the estate of Dorothy A.

Rowan, filed a petition seeking compensation under the National Vaccine Injury Compensation Program. The petition alleged that Ms.

Rowan, who was 91 years old, developed Guillain-Barré syndrome (GBS) following receipt of the influenza vaccine on September 27, 2016. The petition was brought as an off-Table claim because the onset of symptoms occurred within approximately 30 to 36 hours after vaccination, which is shorter than the three-day minimum onset period required for a flu-GBS claim under the Vaccine Injury Table.

Petitioner argued that the flu vaccine caused Ms. Rowan's GBS and that the short onset timeframe was medically acceptable.

Respondent contested this, arguing that the timeframe was too short and that elderly individuals have impaired immune responses. Ms.

Rowan passed away on September 23, 2019, but her death was not attributed to the vaccine. The Special Master denied entitlement.

The public decision does not describe the specific symptoms experienced by Ms. Rowan, nor does it detail the specific diagnostic tests performed beyond general descriptions of MRIs and a neurologist's examination.

The decision also does not name the petitioner's counsel or respondent's counsel. The Special Master was Brian H.

Corcoran. No award amount was granted as the petition was denied.

Theory of causation

Petitioner alleged that the influenza vaccine administered on September 27, 2016, to 91-year-old Dorothy A. Rowan caused Guillain-Barré syndrome (GBS). This was presented as an off-Table claim because the onset of symptoms occurred approximately 30-36 hours post-vaccination, falling outside the three-day minimum required by the Vaccine Injury Table for flu-GBS claims. Petitioner relied on Dr. Lawrence Steinman's opinion that the onset timeframe was medically acceptable, citing the Schonberger study and the Institute of Medicine report, and arguing that an elderly individual's immune response could be rapid. Respondent, through Dr. Arnold Levinson, argued that the 30-36 hour onset was not medically acceptable for vaccine-induced GBS, citing immunosenescence in the elderly and the biological implausibility of such rapid symptom manifestation. Dr. Levinson also questioned the diagnostic validity of GBS in this case. The Special Master, Brian H. Corcoran, denied entitlement, finding that Petitioner failed to establish by a preponderance of the evidence that a 30-36 hour onset of GBS post-vaccination is medically acceptable or that it occurred in this case. The Special Master found Dr. Levinson's arguments more persuasive, noting that the Schonberger study did not support the specific timeframe asserted and that the immune response involves multiple phases that would likely preclude such rapid symptom onset. The decision was issued on May 29, 2020, and the petition was denied with no award granted. Petitioner's counsel was Curtis Webb, and Respondent's counsel was Voris Johnson.

Source PDFs 2 total · 1 downloaded